Stable long-term outcomes after cochlear implantation in subjects with TMPRSS3 associated hearing loss: a retrospective multicentre study-Reference-Cited by-同舟云学术

Stable long-term outcomes after cochlear implantation in subjects with TMPRSS3 associated hearing loss: a retrospective multicentre study

Published:2023-12-15 Issue:1 Volume:52 Page:
ISSN:1916-0216
Container-title:Journal of Otolaryngology - Head & Neck Surgery
language:en
Short-container-title:J of Otolaryngol - Head & Neck Surg

Author:

Fehrmann M. L. A.^ORCID,Huinck W. J.,Thijssen M. E. G.,Haer-Wigman L.,Yntema H. G.,Rotteveel L. J. C.,Widdershoven J. C. C.,Goderie T.,van Dooren M. F.,Hoefsloot E. H.,van der Schroeff M. P.,Mylanus E. A. M.,van Dooren M. F.,Kant S. G.,de Gier H. H. W.,Hoefsloot E. H.,van der Schroeff M. P.,Rotteveel L. J. C.,Ropers F. G.,Kriek M.,Aten E.,Widdershoven J. C. C.,Hof J. R.,Hellingman K.,Vernimmen V.,Kremer H.,Pennings R. J. E.,Feenstra I.,Lanting C. P.,Yntema H. G.,Cals F. L. J.,Haer-Wigman L.,Free R. H.,Wassink-Ruiter J. S. Klein,Smit A. L.,van den Boogaard M. J.,Lachmeier A. M. A.,Smits J. J.,Ebbens F. A.,Maas S. M.,Plomp A.,Goderie T. P. M.,Merkus P.,van de Kamp J.,Lanting C. P.,Pennings R. J. E.,

Abstract

Abstract Background The spiral ganglion hypothesis suggests that pathogenic variants in genes preferentially expressed in the spiral ganglion nerves (SGN), may lead to poor cochlear implant (CI) performance. It was long thought that TMPRSS3 was particularly expressed in the SGNs. However, this is not in line with recent reviews evaluating CI performance in subjects with TMPRSS3-associated sensorineural hearing loss (SNHL) reporting overall beneficial outcomes. These outcomes are, however, based on variable follow-up times of, in general, 1 year or less. Therefore, we aimed to 1. evaluate long-term outcomes after CI implantation of speech recognition in quiet in subjects with TMPRSS3-associated SNHL, and 2. test the spiral ganglion hypothesis using the TMPRSS3-group. Methods This retrospective, multicentre study evaluated long-term CI performance in a Dutch population with TMPRSS3-associated SNHL. The phoneme scores at 70 dB with CI in the TMPRSS3-group were compared to a control group of fully genotyped cochlear implant users with post-lingual SNHL without genes affecting the SGN, or severe anatomical inner ear malformations. CI-recipients with a phoneme score ≤ 70% at least 1-year post-implantation were considered poor performers and were evaluated in more detail. Results The TMPRSS3 group consisted of 29 subjects (N = 33 ears), and the control group of 62 subjects (N = 67 ears). For the TMPRSS3-group, we found an average phoneme score of 89% after 5 years, which remained stable up to 10 years post-implantation. At both 5 and 10-year follow-up, no difference was found in speech recognition in quiet between both groups (p = 0.830 and p = 0.987, respectively). Despite these overall adequate CI outcomes, six CI recipients had a phoneme score of ≤ 70% and were considered poor performers. The latter was observed in subjects with residual hearing post-implantation or older age at implantation. Conclusion Subjects with TMPRSS3-associated SNHL have adequate and stable long-term outcomes after cochlear implantation, equal to the performance of genotyped patient with affected genes not expressed in the SGN. These findings are not in line with the spiral ganglion hypothesis. However, more recent studies showed that TMPRSS3 is mainly expressed in the hair cells with only limited SGN expression. Therefore, we cannot confirm nor refute the spiral ganglion hypothesis.

Funder

Cochlear

Publisher

SAGE Publications

Subject

Otorhinolaryngology,Surgery

Link

https://link.springer.com/content/pdf/10.1186/s40463-023-00680-3.pdf

Reference43 articles.

1. Morton CC, Nance WE. Newborn hearing screening—a silent revolution. N Engl J Med. 2006;354(20):2151–64.

2. Smith R, Shearer AE, Camp G. Hereditary hearing loss homepage 2021. https://hereditaryhearingloss.org/. Accessed Feb 2023.

3. Moon IS, Grant AR, Sagi V, Rehm HL, Stankovic KM. TMPRSS3 gene variants with implications for auditory treatment and counseling. Front Genet. 2021;12:780874.

4. Scott HS, Kudoh J, Wattenhofer M, Shibuya K, Berry A, Chrast R, et al. Insertion of beta-satellite repeats identifies a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness. Nat Genet. 2001;27(1):59–63.

5. Holder JT, Morrel W, Rivas A, Labadie RF, Gifford RH. Cochlear implantation and electric acoustic stimulation in children with TMPRSS3 genetic mutation. Otol Neurotol. 2021;42(3):396–401.